Medpage Today on MSN1mon
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer
The FDA approved the PI3K-pathway inhibitor inavolisib (Itovebi ... and creatinine; and stomatitis; diarrhea; fatigue; rash; ...
Drug sold on Amazon recalled. ‘Hidden drug ingredients’ can cause death and diarrhea
Other possible problems include heart attacks, stroke, stomachaches, internal bleeding, ulceration and skin reactions.
Medpage Today on MSN2d
Early Promise for PI3K Inhibitor in Brain Metastases
HOUSTON -- Two-thirds of patients with PI3K -mutant brain metastases responded to the maximum tolerated dose (MTD) of the ...
precisionmedicineonline2d
Roche's Itovebi Poised to Shake Up Competitive Landscape for PI3K Inhibitors
In the absence of head-to-head studies, oncologists are looking across pivotal trials and are encouraged by Itovebi's safety and efficacy versus Piqray.
The American Journal of Managed Care5y
The PI3K Pathway: The Benefits of Dual Inhibition in Follicular Lymphoma
13 In a safety analysis, TEAEs included diarrhea (48.8%), nausea (29.5% ... Data accumulated to date with respect to various PI3K inhibitors suggest improved response rates and longer survival ...
Nature5y
Infinity and Intellikine to develop oral PI3K inhibitors for inflammatory diseases
Infinity Pharmaceuticals has gained access to Intellikine's portfolio of phosphoinositide 3-kinase-δ (PI3Kδ) and PI3Kγ inhibitors for inflammation and oncology indications through an exclusive ...